Written Question · S2W-19087 · Session 2
When NHS Quality Improvement Scotland will make its announcement on donepezil, rivastigmine, galantamine and memantine for the treatment of…
The question
To ask the Scottish Executive when NHS Quality Improvement Scotland will make its announcement on donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease.
The answer
NHS Quality Improvement Scotland will consider any final recommendation from the National Institute for Health and Clinical Excellence (NICE) on this matter and consider how it might apply to NHS Scotland. NICE is currently gathering further information on these drugs from the respective manufacturers.
In the Official Report
No contribution in the Official Report cites S2W-19087 by reference.